Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Virtual reality hand displays to change tremor in functional movement disorder

Official title: The Effect of Virtual Hand Movements on Functional Tremor - a Pilot Study

Run by Medical University of Graz · NCT06393439 · Data updated 2026-11-12

This study tests whether changing how virtual hands are shown during a VR motor task can improve hand movement and reduce tremor in people with functional tremor compared with essential tremor patients and healthy volunteers.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment48 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz)
StatusRecruiting
StartedMay 1, 2024
Main results expectedDecember 31, 2025
Study endsMarch 30, 2026
Registry record updatedSeptember 29, 2025
Trial IDNCT06393439 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults diagnosed with functional tremor who can attend in-person visits and perform VR motor tasks, alongside comparator groups of essential tremor patients and healthy volunteers.

Probably not a fit

People with unclear or mixed tremor syndromes, implanted devices like pacemakers or DBS, skin conditions that interfere with EEG, or other exclusions listed are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use virtual reality motor tasks with different virtual hand display modes and manipulated visual feedback to measure effects on hand movement performance, tremor amplitude, and subjective tremor perception. Three groups—patients with functional tremor, patients with essential tremor, and healthy controls—will complete one or two visits including clinical ratings and a 2.5-hour VR testing session at the University of Graz. Patients with tremor have an initial neurological exam with standardized severity scales (CGI-S, PGI-S, FTM, S-FMDRS) before the VR session; healthy controls attend only the VR session. Participants are asked to avoid tremor-influencing medications on the test day and those with medical or EEG-interfering conditions are excluded.

Why it matters

Potential benefit: If successful, this approach could provide a noninvasive way to reduce functional tremor symptoms or inform personalized visual-feedback rehabilitation.

How similar studies have gone: Some small studies of visual feedback and VR in functional neurological disorders and tremor have shown promising preliminary results, but the specific manipulations of virtual hand displays used here are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of functional tremor (FT) or essential tremor (ET) or healthy control persons
* In patients with FT and ET: presence of a constant or intermittent tremor during the neurological examination

Exclusion Criteria:

* unclear tremor syndrome
* essential tremor plus (ET plus)
* conditions that interfere with EEG diagnostic (skin conditions, skin infections, wounds)
* reflex epilepsy
* cervical degeneration or chronic pain syndrome of the cervical spine
* severe somatic illness
* previous cerebral or head surgery
* implanted pacemaker or deep brain stimulation
* persons who are unable to consent

Where it's running

  • Medical University of Graz, Department of Neurology
    Graz, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.